COLL Q3 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$12M+2828.9% YoY

Gross Profit

$11M95.4% margin

Operating Income

-$13M-112.4% margin

Net Income

-$13M-111.0% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+235.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$123M

Total Liabilities

$26M

Stockholders' Equity

$96M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$408,000	+2828.9%
Gross Profit	$11M	$379,000	+2907.1%
Operating Income	-$13M	-$26M	+49.2%
Net Income	-$13M	-$26M	+49.8%